Cite
HARVARD Citation
Scosyrev, E. et al. (2021). Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials. Respiratory medicine. p. . [Online].